Released: February 4, 2021
Department of Defense Neurofibromatosis Research Program
Anticipated Funding Opportunities for Fiscal Year 2021 (FY21)
The FY21 Defense Appropriations Act provides funding to the Department of Defense Neurofibromatosis Research Program (NFRP) to support innovative, high-impact Neurofibromatosis (NF) research. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).
The NFRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY21 funding opportunities. This pre-announcement should not be construed as an obligation by the Government. The FY21 NFRP Program Announcements and General Application Instructions for the following award mechanisms will be posted on the Grants.gov website. Pre-application and application deadlines will be available when the Program Announcements are released.
Areas of Emphasis: The NFRP encourages applications that specifically address the critical needs of the NF community in one or more of the FY21 Areas of Emphasis. Not all Areas of Emphasis are applicable to each award mechanism offered by the FY21 NFRP. If the proposed research project does not address one of the FY21 Areas of Emphasis, justification that the proposed research project addresses an important problem related to NF research and/or patient care should be provided. Applications submitted to the FY21 NFRP must address one or more of the following Areas of Emphasis:
- Biomarker discovery, utility, development, and validation
- Non-tumor manifestations not limited to:
- Cognitive Manifestations
- Heterogeneity of NF-related tumors
- Novel disease and treatment response markers using genetics, genomics, epigenetics, systems biology, metabolomics, or similar approaches
- Preclinical efficacy studies
- Target identification, drug discovery
- Nutritional, environmental, and other modifiers of NF
- Health services research
|Award Mechanism||Eligibility||Key Mechanism Elements||Funding|
|Clinical Trial Award||Investigators at or above the level of Assistant Professor (or equivalent).||
|Clinical Trials Consortium Award (NEW for FY21)||TBD||
|Exploration - Hypothesis Development Award||All academic levels (or equivalent).||
|Investigator-Initiated Research Award||Investigators at or above the level of Assistant Professor (or equivalent) and must plan to commit at least a 10% level of effort for each budget period throughout the entirety of the award.||
|New Investigator Award||Investigators at or below the level of Assistant Professor (or equivalent) or an established investigator at or above the level of Assistant Professor seeking to transition into a career in NF research.||
|Early Investigator Research Award||
|Synergistic Idea Award (NEW for FY20)||Investigators at or above the level of Assistant Professor (or equivalent).||
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Submission deadlines are not available until the Program Announcements are released. For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the NFRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).
Point of Contact:
CDMRP Public Affairs